The Food and Drug Administration (FDA) is claiming in federal court that it never told doctors not to prescribe ivermectin to treat COVID-19. Federal judges aren’t buying it, and state medical boards that rely heavily on FDA guidance continue to investigate doctors for such prescriptions.
Echoing a federal district judge nine months ago, a three-judge panel of the 5th U.S. Circuit Court of Appeals pressed a Justice Department lawyer to reconcile the FDA’s repeated public denunciations of ivermectin as an off-label COVID treatment with its insistence that the agency is not liable for resulting investigations of doctors who prescribe or promote it.
One of the nation’s leading epidemiologists is declaring there is no basis for President Joe Biden to extend his emergency pandemic powers and that it is essential for insurers to release data showing deaths and injuries to those who have received COVID-19 vaccines.
Dr. Harvey Risch, professor emeritus at the Yale University School of Public Health, told Just the News on Friday evening that federal agencies have epically mishandled the pandemic strategy by substituting theories and politics for science.
Various medical boards, and now even a California bill, threaten doctors who have exercised their independence from the government’s narrative in their efforts to discuss the risks of the COVID mRNA shots and the benefits of early treatments for COVID-19 with their patients.
Certification boards such as the American Board of Internal Medicine (ABIM), the American Board of Obstetrics & Gynecology (ABOG), and the American Board of Family Medicine (ABFM) have all been named in a federal lawsuit filed in July by the Association of American Physicians and Surgeons Educational Foundation (AAPS) in U.S. District Court for the Southern District of Texas.